Dr. Manuprasad A

• Gold medals in General medicine,General Surgery and Ophthalmology During MBBS ( Government Medical College ,Thiruvananthapuram) 
• Professor Ramachandran Memorial Gold medal in Pathology (2006)- 
• Best outgoing student Government Medical College Thiruvananthapuram (2008)
• Best outgoing student General Medicine Govt Medical college Kozhikode ( 2013)
• Merit grant for Advanced Course in Biomarkers for Precision Medicine conducted by ESMO (European Society Of Medical Oncology) in October 2022 at Singapore
• Best abstract award in the 12th annual conference of Indian Society of study in Lung cancer 2021 (NALLCON)
• European Society Of Medical Oncology merit travel grant for ESMO ASIA 2022 8) Best Poster Award – in the category of Genitourinary - Prostate Cancer in European society of Medical Oncology Asia Conference 2022 held at Singapore

Publications

• Experience with Nilotinib in Indian patients with CML Manuprasad, A., Ganesan, P., Ganesan, T.S. et al. Indian J Hematology and Blood Transfusion (2017). https://doi.org/10.1007/s12288-017-0877-x 
• Hepatoblastoma: 16-years’ experience from a tertiary cancer centre in India Manuprasad A, Venkatraman R Paediatric Hematology Oncology Journal (Jan 2018) https://doi.org/10.1016/j.phoj.2018.01.002
• Health related quality of life in patients with multiple myeloma on novel agents – report from a tertiary cancer centre in rural India. Vineetha Raghavan, Manuprasad A, PB Sajeev Kumar, Zoheb Raj, P K Shenoy, Chandran K Nair Cancer Res Stat Treat 2018;1:92-5 
• Short course adjuvant trastuzumab in breast cancer :Experience from a tertiary cancer centre in rural India. Manuprasad A,Shenoy P K,Vinin NV et al .Cancer Res Stat Treat 220:3:69-73
• Infection at diagnosis-a unique challenge in acute myeloid leukemia treatment in developing world . Pandian J, Raghavan V, Manuprasad A, Shenoy PK, Nair CK. Support Care Cancer. 2020;10.1007/s00520-020-05379-z. doi:10.1007/s00520-020-05379-z
• Docetaxel-induced lung injury: An under-recognized complication of a commonly used chemotherapeutic agent. Manuprasad A, Ganesan P, Mahajan V, Ganesan TS, Radhakrishnan V, Dhanushkodi M, Sagar TG. Indian J Med Paediatr Oncol 2019;40:208-11
• Toxicity profile of weekly regimen of paclitaxel in patients with non-metastatic breast cancer-a real world experience. Praveen Kumar Shenoy , Isharath Ebrahim , Anitha Mary Skaria , Manuprasad A Oncology and Radiotherapy Vol. 15 Iss.2:009-012
• Gemcitabine, dexamethasone, and cisplatin salvage in relapsed lymphomas: A single institutional experience. Manuprasad A, Shenoy PK, Raghavan V, Shiljina K M, Nair CK Cancer Res Stat Treat 2020;3:13-8
• Unmet need in patients with multiple myeloma-a cross sectional study from India . Avaronnan Manuprasad, Vineetha Raghavan, Sajeev Kumar PB, Zoheb Raj, Praveen Kumar Shenoy, Chandran K Nair Oncology and Radiotherapy 1 (46) 2019: 090-094
• Impact of active tuberculosis on treatment decisions in cancer. Chandran K. Nair, Manuprasad Avaronnan, Praveen Kumar Shenoy, Vineetha Raghavan, Priya Jayarajan, Parthiban Rudrapathy, Karthickeyan Duraisamy, Satheesan Balasubramanian, Current
• Problems in Cancer, 2020,100643ISSN 0147 0272,https://doi.org/10.1016/j.currproblcancer.2020.100643
• The utility of day 14 bone marrow response assessment in patients undergoing acute myeloid leukemia induction: A single-institution retrospective experience. Manuprasad A, Raghavan V, Shenoy PK, Krishnan A, Nair CK. Cancer Res Stat Treat 2021;4:628-33
• Fear of Recurrence and Somatic Symptom Severity in Multiple Myeloma Patients: An Institution-Based Cross-Sectional Study. Praveen Kumar Shenoy V P,Vineetha Raghavan,Avaronnan Manuprasad,Sajeev Kumar P. B.,Zoheb Raj,Chandran K. Nair. Indian J Med Paediatr Oncol 2022 4304 355-360 DOI DOI 101055s-0042-1755302. 
• Pattern of extranodal involvement and its impact on survival in diffuse large B-cell lymphoma from a tertiary cancer center in rural India. CK Nair, AR Kurup, A Manuprasad, PK Shenoy, V Raghavan Journal of Cancer Research and Therapeutics 17 (4), 938 14) Neoadjuvant Platinum Based Chemotherapy in Triple Negative Breast Cancer-Preliminary Experience from A Tertiary Cancer Centre. Praveen Kumar Shenoy, Joneetha Jones, Vinin N V, Manuprasad A, Geetha M And Priya Rathi Int J Pharm Bio Sci Vol 12 Issue 2 2021 April-June Pages71-77.
• Treatment pattern and outcomes in patients with uncommon or compound EGFR mutations in India: CRSF 2020-03 study. Manuprasad Avaronnan, Rushabh Kothari, Avinash Talele, Vikas Talreja, Gautam Goyal, Nirmal Vivek Raut, and Ashay Karpe . Journal of Clinical Oncology 2022 40:16_suppl, e21034-e21034
• 163P Outcomes and toxicity of fosfesterol in metastatic castration-resistant prostate cancer: Experience from a low middle income country M. Avaronnan, M. et al. Annals of Oncology, Volume 33, S1498 
• 24P Outcomes of patients with HER2 positive metastatic breast cancer treated with low dose or metronomic lapatinib. Mathew, S.P., Manuprasad Avaronnan,VP Shenoy,Nandini devi R Annals of Oncology, Volume 33, S1439 
• Utility of annual surveillance mammography in patients with treated breast cancer- A single institutional experience from India. Manuprasad Avaronnan, Sreelakshmi Soman,Satheesh Babu TV,Geetha Muttath Oncologyand Radiotherapy © 16 (12) 2022: 089-092 •
• Oral metronomic chemotherapy as a feasible preoperative therapy in advanced resectable oral cavity squamous cell carcinomas – a preliminary experience. Shenoy V
• P Praveen Kumar, Manuprasad Avaronnan, Babu Sajith, Aravind Sithara, Narayanan Vinin N, Nayanar Sangeetha, Balasubramanian Satheesan ecancer 16 1425 (2022)